<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="species">human</item><item key="factors"><item><item key="GSE2883GSM63081"><item key="COMPOUND">thapsigargin</item></item></item><item><item key="GSE2883GSM63086"><item key="COMPOUND">high potassium</item></item></item><item><item key="GSE2883GSM63077"><item key="COMPOUND">control</item></item></item><item><item key="GSE2883GSM63086"><item key="COMPOUND">high potassium</item></item></item><item><item key="GSE2883GSM63081"><item key="COMPOUND">thapsigargin</item></item></item><item><item key="GSE2883GSM63077"><item key="COMPOUND">control</item></item></item><item><item key="GSE2883GSM63077"><item key="COMPOUND">control</item></item></item><item><item key="GSE2883GSM63081"><item key="COMPOUND">thapsigargin</item></item></item><item><item key="GSE2883GSM63086"><item key="COMPOUND">high potassium</item></item></item></item><item key="id">1438</item><item key="pop_total">0</item><item key="platform">3</item><item key="summary_wrapped">Altered Ca2+ handling has both immediate physiological effects and long-term genomic effects on vascular smooth muscle function....</item><item key="pubmed_id">16461377</item><item key="geo_gse_id">E-GEOD-2883</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">1</item><item key="sample_count">9</item><item key="tags"><item>cell</item><item>left</item><item>membrane</item><item>muscle</item><item>protein</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">transcription-profilfing-of-human-cerebrovascular</item><item key="geo_id_plat">E-GEOD-2883_A-AFFY-33</item><item key="name">Transcription profilfing of human cerebrovascular smooth muscle to identify Ca2+-dependent transcription patterns</item><item key="created">Jun.19, 2014</item><item key="summary">Altered Ca2+ handling has both immediate physiological effects and long-term genomic effects on vascular smooth muscle function.  Previously we have shown that elevation of cytoplasmic Ca2+ through voltage-dependent Ca2+ channels (VDCCs) or store-operated Ca2+ channels (SOCCs) results in phosphorylation of the Ca2+/cAMP response element binding protein (CREB) in cerebral arteries.  Here we demonstrate that stimulation of these different Ca2+ influx pathways results in transcriptional activation of a distinct, yet overlapping set of genes, and that the induction of selected CRE-regulated genes is prevented by the addition of corresponding Ca2+ channel blockers.  Using oligonucleotide array analysis, changes in mRNA levels were quantified following membrane depolarization with K+ or depletion of intracellular Ca2+ stores with thapsigargin in human cerebral vascular smooth muscle cells.  Array results for differentially regulated genes containing a CRE were confirmed by quantitative RT-PCR, and corresponding changes in protein expression were shown by Western blot analysis and immunofluorescence.  Membrane depolarization induced a transient increase in c-fos mRNA and a sustained increase in early growth response-1 (Egr-1) mRNA and protein that were inhibited by application of the VDCC blocker, nimodipine, and the SOCC inhibitor, 2-aminoethoxydiphenylborate (2-APB).  Thapsigargin induced a sustained increase in c-fos mRNA and MAP kinase phosphatase-1 (MKP-1) mRNA and protein, and these effects were decreased by 2-APB but not by nimodipine.  Our findings thus indicate that Ca2+ entry through VDCCs and SOCCs can differentially regulate CRE-containing genes in vascular smooth muscle and imply that signals involved in growth modulation are both temporally and spatially regulated by Ca2+.   Experiment Overall Design: each of three experiments cell cultures were split three ways; one of the resulting samples was left untreated (C), another was treated with thapsigargin (TG), and the third was treated with elevated K+ (K).   The resulting nine samples were used for triplicate estimates of the response of each gene to TG and K treatments. Experiment Overall Design: We tested the prospective hypothesis that genes having a CRE are differentially expressed after TG or K treatment using a permutation test: each of the 22,283 probe sets on the Affymetrix GeneChip was categorized two ways based on 1) whether or not it contains a CRE or not  .   Independence of CRE and threshold differential expression was rejected by Fisher&#8217;s exact test for both TG treatment ( ) and K treatment ( ).   Target genes (c-fos, egr-1, and mkp-1 ) were identified based on    ranking.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-2883</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-2883/samples/</item></data></biogps>
